Grants and Contributions:
Title:
UI optimization of Molecular DeCOde Rx diagnostic Software engine
Agreement Number:
1022567
Agreement Value:
$75,000.00
Agreement Date:
Sep 2, 2024 - Mar 25, 2025
Description:
The project aims to further improve and enhance its existing minimum viable product (MVP) in the areas of cybersecurity and user interface for its Molecular DeCOde Rx Oncology Diagnostic technology.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Calgary, Alberta, CA T2L 1Y8
Reference Number:
172-2024-2025-Q2-1022567
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
753382282
Recipient Type:
For-profit organization
Recipient's Operating Name:
Qualisure Diagnostics Inc.
Recipient's Legal Name:
Qualisure Diagnostics Inc.
Federal Riding Name:
Calgary Confederation
Federal Riding Number:
48005
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
6215